Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Fujiwara

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Immunotherapy|February 6, 2025
Encouraging co-targeting of immunoregulatory molecules in cancer treatmentTakumi Sato, Yu Fujiwara
The New England Journal of Medicine|January 17, 2024
Perioperative Durvalumab for Resectable Non-Small-Cell Lung CancerNobuyuki Horita, Yu Fujiwara
Surgical Oncology Clinics of North America|February 24, 2024
Evolution of Precision Oncology, Personalized Medicine, and Molecular Tumor BoardsYu Fujiwara, Shumei Kato, Razelle Kurzrock
Psychiatry Research|September 24, 2022
Further information for comparing Cognitive and emotional remediation training for depression (CERT-D) with existing psychotherapiesYu Fujiwara, Kayoko Morio, Yuki Kataoka
Urology Case Reports|June 19, 2019
Multiple osteolytic bone and lung metastases from prostate cancer including small cell carcinoma with marked increases in CEA and Pro-GRPShun Okamura, Yu Fujiwara, Kaoru Nagata
JCO Oncology Practice|July 10, 2020
Granulocyte Colony-Stimulating Factor-Associated Aortitis: Treatment Suggestion for This ComplicationYu Fujiwara, Takeshi Yamaguchi, Minoru Nakane
Internal Medicine (Tokyo, Japan)|August 14, 2020
Portal Vein Thrombosis in Metastatic Colorectal Cancer During FOLFIRI-bevacizumab Chemotherapy Successfully Treated with ApixabanYu Fujiwara, Takeshi Yamaguchi, Minoru Nakane
Cancer Immunology, Immunotherapy : CII|December 10, 2022
First-line therapy for elderly patients with advanced renal cell carcinoma in the immuno-oncology era: a network meta-analysisYu Fujiwara, Hirotaka Miyashita, Bobby C Liaw
The Lancet. Oncology|February 29, 2024
Accurately addressing double-arm-zero-events studies in meta-analyses - Authors' replyYu Fujiwara, Nobuyuki Horita, Abdul Rafeh Naqash
Journal of Immunotherapy and Precision Oncology|August 29, 2022
Targeting <i>KRAS</i>: Crossroads of Signaling and Immune InhibitionShumei Kato, Yu Fujiwara, David S Hong
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Immunotherapy|February 6, 2025
Encouraging co-targeting of immunoregulatory molecules in cancer treatmentTakumi Sato, Yu Fujiwara
The New England Journal of Medicine|January 17, 2024
Perioperative Durvalumab for Resectable Non-Small-Cell Lung CancerNobuyuki Horita, Yu Fujiwara
Surgical Oncology Clinics of North America|February 24, 2024
Evolution of Precision Oncology, Personalized Medicine, and Molecular Tumor BoardsYu Fujiwara, Shumei Kato, Razelle Kurzrock
Psychiatry Research|September 24, 2022
Further information for comparing Cognitive and emotional remediation training for depression (CERT-D) with existing psychotherapiesYu Fujiwara, Kayoko Morio, Yuki Kataoka
Urology Case Reports|June 19, 2019
Multiple osteolytic bone and lung metastases from prostate cancer including small cell carcinoma with marked increases in CEA and Pro-GRPShun Okamura, Yu Fujiwara, Kaoru Nagata
JCO Oncology Practice|July 10, 2020
Granulocyte Colony-Stimulating Factor-Associated Aortitis: Treatment Suggestion for This ComplicationYu Fujiwara, Takeshi Yamaguchi, Minoru Nakane
Internal Medicine (Tokyo, Japan)|August 14, 2020
Portal Vein Thrombosis in Metastatic Colorectal Cancer During FOLFIRI-bevacizumab Chemotherapy Successfully Treated with ApixabanYu Fujiwara, Takeshi Yamaguchi, Minoru Nakane
Cancer Immunology, Immunotherapy : CII|December 10, 2022
First-line therapy for elderly patients with advanced renal cell carcinoma in the immuno-oncology era: a network meta-analysisYu Fujiwara, Hirotaka Miyashita, Bobby C Liaw
The Lancet. Oncology|February 29, 2024
Accurately addressing double-arm-zero-events studies in meta-analyses - Authors' replyYu Fujiwara, Nobuyuki Horita, Abdul Rafeh Naqash
Journal of Immunotherapy and Precision Oncology|August 29, 2022
Targeting <i>KRAS</i>: Crossroads of Signaling and Immune InhibitionShumei Kato, Yu Fujiwara, David S Hong
Pageof 7